Drug & intervention

armodafinil

RxCUI 641465

Clinical trials16

Recruiting0

Related conditions19

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

16 shown

A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and ArmodafinilNCT01317550 · 2011-07-01

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01305408 · 2011-03-01

Management of Insomnia in Breast Cancer PatientsNCT01011218 · 2011-01-01

Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy BodiesNCT01256905 · 2011-01-01

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01121536 · 2010-04-30

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01072630 · 2010-03-01

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01072929 · 2010-01-01

Armodafinil in Binge Eating Disorder (BED)NCT01010789 · 2009-11-01

Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)NCT00981084 · 2009-09-01

Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With SchizophreniaNCT00772005 · 2008-09-01

Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDSNCT00737204 · 2008-06-01

Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following ChemotherapyNCT01091974 · 2008-02-01

Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and DepressionNCT00518986 · 2007-10-01

Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive DeficitsNCT00487942 · 2007-07-01

Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT00481195 · 2007-06-01

Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)NCT01048983

Conditions being studied

Depression4 Fatigue3 Insomnia2 Schizophrenia2 Binge Eating Disorder1 Bipolar I Depression1 Breast Cancer1 Dysthymic Disorder1 HIV Infections1 Lewy Bodies Disease1 Lung Cancer1 Major Depressive Disorder1 Multiple Sclerosis1 Non Small Cell Lung Cancer1 Obese1 Obstructive Sleep Apnea1 Overweight1 Parkinsons Disease1 Sleep Disorders1

Research locations

AtlantaGeorgia, United States8 New YorkNew York, United States8 BrooklynNew York, United States7 San DiegoCalifornia, United States7 TampaFlorida, United States7 AustinTexas, United States6 Staten IslandNew York, United States6 BellevueWashington, United States5 BirminghamAlabama, United States5 DaytonOhio, United States5 Oklahoma CityOklahoma, United States5 PhiladelphiaPennsylvania, United States5

Leading sponsors

Cephalon8 M.D. Anderson Cancer Center2 Lindner Center of HOPE1 New York State Psychiatric Institute1 NYU Langone Health1 Stanford University1 University of Missouri, Kansas City1 University of Rochester1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.